Abstract

Antiphospholipid syndrome (APS) is a rare systemic autoimmune disease, the obstetric features of which include recurrent early miscarriage, fetal death at or beyond 10 weeks of gestation, and early delivery for severe preeclampsia or placental insufficiency. Controversies regarding the specificity of these obstetric clinical features, as well as the laboratory diagnostic criteria, are the subject of current debate and reanalysis. Clinical and laboratory features can be used to stratify women with APS in terms of risk of adverse second and third trimester pregnancy outcomes. Numerous “treatments” have been used in high-risk and refractory patients, but rigorously designed clinical trials are needed. APS is a rare disease that requires innovative investigative approaches to provide credible results.

References

References
1.
Miyakis
S
,
Lockshin
MD
,
Atsumi
T
, et al
.
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
.
J Thromb Haemost
.
2006
;
4
(
2
):
295
-
306
.
2.
Barbhaiva
M
,
Zuily
S
,
Ahmadzadeh
Y
,
Naden
RP
,
Costenbader
K
,
Erkan
D
.
Development of new international classification criteria for antiphospholipid syndrome: phase II item reduction survey [abstract]
.
Arthritis Rheumatol
.
2018
;
70
(
suppl 10
). Abstract 163.
3.
Duarte-Garcia
A
,
Pham
MM
,
Crowson
CS
, et al
.
The epidemiology of antiphospholipid syndrome. A population-based study
.
Arthritis Rheumatol
.
2019
;
71
(
9
):
1545
-
1552
.
4.
Andreoli
L
,
Chighizola
CB
,
Banzato
A
,
Pons-Estel
GJ
,
Ramire de Jesus
G
,
Erkan
D
.
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature
.
Arthritis Care Res (Hoboken)
.
2013
;
65
(
11
):
1869
-
1873
.
5.
Clark
CA
,
Laskin
CA
,
Spitzer
KA
.
Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence
.
Hum Reprod Update
.
2012
;
18
(
5
):
474
-
484
.
6.
de Jesus
GR
,
Agmon-Levin
N
,
Andrade
CA
, et al
.
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome
.
Autoimm Rev
.
2014
;
13
:
795
-
813
.
7.
Pengo
V
,
Ruffatti
A
,
Del Ross
T
, et al
.
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
.
J Thromb Haemost
.
2013
;
11
(
8
):
1527
-
1531
.
8.
Clark
CA
,
Davidovits
J
,
Spitzer
KA
,
Laskin
CA
.
The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic
.
Blood
.
2013
;
122
(
3
):
341
-
347
.
9.
Cohn
DM
,
Goddijn
M
,
Middeldorp
S
,
Korevaar
JC
,
Dawood
F
,
Farquharson
RG
.
Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy
.
J Thromb Haemost
.
2010
;
8
(
10
):
2208
-
2213
.
10.
Bowman
ZS
,
Wünsche
V
,
Porter
TF
,
Silver
RM
,
Branch
DW
.
Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss
.
J Reprod Immunol
.
2015
;
107
:
59
-
63
.
11.
Shi
W
,
Krilis
SA
,
Chong
BH
,
Gordon
S
,
Chesterman
CN
.
Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population
.
Aust N Z J Med
.
1990
;
20
(
3
):
231
-
236
.
12.
de Groot
PG
,
Lutters
B
,
Derksen
RHWM
,
Lisman
T
,
Meijers
JCM
,
Rosendaal
FR
.
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
.
J Thromb Haemost
.
2005
;
3
(
9
):
1993
-
1997
.
13.
Cervera
R
,
Piette
JC
,
Font
J
, et al
;
Euro-Phospholipid Project Group
.
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
.
Arthritis Rheum
.
2002
;
46
(
4
):
1019
-
1027
.
14.
Helgadottir
LB
,
Skjeldestad
FE
,
Jacobsen
AF
,
Sandset
PM
,
Jacobsen
E-M
.
The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study
.
Thromb Res
.
2012
;
130
(
1
):
32
-
37
.
15.
Silver
RM
,
Parker
CB
,
Reddy
UM
, et al
.
Antiphospholipid antibodies in stillbirth
.
Obstet Gynecol
.
2013
;
122
(
3
):
641
-
657
.
16.
Bouvier
S
,
Cochery-Nouvellon
E
,
Lavigne-Lissalde
G
, et al
.
Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study
.
Blood
.
2014
;
123
(
3
):
404
-
413
.
17.
Lockshin
MD
,
Kim
M
,
Laskin
CA
, et al
.
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
.
Arthritis Rheum
.
2012
;
64
(
7
):
2311
-
2318
.
18.
Gibbins
KJ
,
Tebo
AE
,
Nielsen
SK
,
Branch
DW
.
Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study
.
Lupus
.
2018
;
27
(
12
):
1903
-
1910
.
19.
Giannakopoulos
B
,
Krilis
SA
.
The pathogenesis of the antiphospholipid syndrome
.
N Engl J Med
.
2013
;
368
(
11
):
1033
-
1044
.
20.
Abrahams
VM
,
Chamley
LW
,
Salmon
JE
.
Emerging treatment models in rheumatology: antiphospholipid syndrome and pregnancy: pathogenesis to translation
.
Arthritis Rheumatol
.
2017
;
69
(
9
):
1710
-
1721
.
21.
Holers
VM
,
Girardi
G
,
Mo
L
, et al
.
Complement C3 activation is required for antiphospholipid antibody-induced fetal loss
.
J Exp Med
.
2002
;
195
(
2
):
211
-
220
.
22.
Girardi
G
,
Berman
J
,
Redecha
P
, et al
.
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
.
J Clin Invest
.
2003
;
112
(
11
):
1644
-
1654
.
23.
Berman
J
,
Girardi
G
,
Salmon
JE
.
TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss
.
J Immunol
.
2005
;
174
(
1
):
485
-
490
.
24.
Stone
S
,
Pijnenborg
R
,
Vercruysse
L
, et al
.
The placental bed in pregnancies complicated by primary antiphospholipid syndrome
.
Placenta
.
2006
;
27
(
4-5
):
457
-
467
.
25.
Erlendsson
K
,
Steinsson
K
,
Jóhannsson
JH
,
Geirsson
RT
.
Relation of antiphospholipid antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus
.
J Rheumatol
.
1993
;
20
(
10
):
1779
-
1785
.
26.
Ruffatti
A
,
Tonello
M
,
Visentin
MS
, et al
.
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study
.
Rheumatology (Oxford)
.
2011
;
50
(
9
):
1684
-
1689
.
27.
Ruffatti
A
,
Tonello
M
,
Del Ross
T
, et al
.
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity
.
Thromb Haemost
.
2006
;
96
(
3
):
337
-
341
.
28.
Ruffatti
A
,
Tonello
M
,
Cavazzana
A
,
Bagatella
P
,
Pengo
V
.
Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy
.
Thromb Res
.
2009
;
123
(
3
):
482
-
487
.
29.
Saccone
G
,
Berghella
V
,
Maruotti
GM
, et al
.
Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study
.
Am J Obstet Gynecol
.
2017
;
216
(
5
):
525.e1
-
525.e12
.
30.
Simchen
MJ
,
Dulitzki
M
,
Rofe
G
, et al
.
High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome
.
Acta Obstet Gynecol Scand
.
2011
;
90
(
12
):
1428
-
1433
.
31.
Ruffatti
A
,
Olivieri
S
,
Tonello
M
, et al
.
Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification
.
J Thromb Haemost
.
2008
;
6
(
10
):
1693
-
1696
.
32.
Li
R
,
Daguzan
M
,
Vandermijnsbrugge
F
,
Gyling
M
,
Cantinieaux
B
.
Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis
.
Acta Clin Belg
.
2014
;
69
(
6
):
433
-
438
.
33.
Kutteh
WH
.
Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
.
Am J Obstet Gynecol
.
1996
;
174
(
5
):
1584
-
1589
.
34.
Farquharson
RG
,
Quenby
S
,
Greaves
M
.
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment
.
Obstet Gynecol
.
2002
;
100
(
3
):
408
-
413
.
35.
Rai
R
,
Cohen
H
,
Dave
M
,
Regan
L
.
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
.
BMJ
.
1997
;
314
(
7076
):
253
-
257
.
36.
Laskin
CA
,
Spitzer
KA
,
Clark
CA
, et al
.
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial
.
J Rheumatol
.
2009
;
36
(
2
):
279
-
287
.
37.
Goel
N
,
Tuli
A
,
Choudhry
R
.
The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies
.
Med Sci Monit
.
2006
;
12
(
3
):
CR132
-
CR136
.
38.
Alalaf
S
.
Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome
.
Arch Gynecol Obstet
.
2012
;
285
(
3
):
641
-
647
.
39.
Silver
RK
,
MacGregor
SN
,
Sholl
JS
,
Hobart
JM
,
Neerhof
MG
,
Ragin
A
.
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients
.
Am J Obstet Gynecol
.
1993
;
169
(
6
):
1411
-
1417
.
40.
Pattison
NS
,
Chamley
LW
,
Birdsall
M
,
Zanderigo
AM
,
Liddell
HS
,
McDougall
J
.
Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial
.
Am J Obstet Gynecol
.
2000
;
183
(
4
):
1008
-
1012
.
41.
Bramham
K
,
Thomas
M
,
Nelson-Piercy
C
,
Khamashta
M
,
Hunt
BJ
.
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss
.
Blood
.
2011
;
117
(
25
):
6948
-
6951
.
42.
Mekinian
A
,
Lazzaroni
MG
,
Kuzenko
A
, et al
;
SNFMI and the European Forum on Antiphospholipid Antibodies
.
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study
.
Autoimmun Rev
.
2015
;
14
(
6
):
498
-
502
.
43.
Sciascia
S
,
Hunt
BJ
,
Talavera-Garcia
E
,
Lliso
G
,
Khamashta
MA
,
Cuadrado
MJ
.
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies
.
Am J Obstet Gynecol
.
2016
;
214
(
2
):
273.e1
-
273.e8
.
44.
Ruffatti
A
,
Favaro
M
,
Hoxha
A
, et al
.
Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study
.
J Reprod Immunol
.
2016
;
115
:
14
-
19
.
45.
Frampton
G
,
Cameron
JS
,
Thom
M
,
Jones
S
,
Raftery
M
.
Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone
.
Lancet
.
1987
;
2
(
8566
):
1023
-
1024
.
46.
Kobayashi
S
,
Tamura
N
,
Tsuda
H
,
Mokuno
C
,
Hashimoto
H
,
Hirose
S
.
Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy
.
Ann Rheum Dis
.
1992
;
51
(
3
):
399
-
401
.
47.
Nakamura
Y
,
Yoshida
K
,
Itoh
S
, et al
.
Immunoadsorption plasmapheresis as a treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies
.
Am J Reprod Immunol
.
1999
;
41
(
5
):
307
-
311
.
48.
El-Haieg
DO
,
Zanati
MF
,
El-Foual
FM
.
Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome
.
Int J Gynaecol Obstet
.
2007
;
99
(
3
):
236
-
241
.
49.
Ruffatti
A
,
Marson
P
,
Pengo
V
, et al
.
Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature
.
Autoimmun Rev
.
2007
;
6
(
3
):
196
-
202
.
50.
Bortolati
M
,
Marson
P
,
Chiarelli
S
, et al
.
Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome
.
Ther Apher Dial
.
2009
;
13
(
2
):
157
-
160
.
51.
Mayer-Pickel
K
,
Horn
S
,
Lang
U
,
Cervar-Zivkovic
M.
Response to plasmapheresis measured by angiogenic factors in a woman with antiphospholipid syndrome in pregnancy
.
Case Rep Obstet Gynecol
.
2015
;
2015
:
123408
.
52.
Ruffatti
A
,
Tonello
M
,
Hoxha
A
, et al
.
Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study
.
Thromb Haemost
.
2018
;
118
(
4
):
639
-
646
.
53.
Lefkou
E
,
Mamopoulos
A
,
Fragakis
N
, et al
.
Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin
.
Hypertension
.
2014
;
63
(
5
):
e118
-
e119
.
You do not currently have access to this content.